Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals Limited has submitted a copy of its newspaper publication to the NSE, containing the audited (both standalone and consolidated) financial results for the quarter and full year ended March 31, 2025. This is a routine compliance filing required under SEBI listing regulations, where listed companies must publish their financial results in newspapers for public information. No specific financial figures, revenue numbers, or profit details are disclosed in this particular announcement. Shareholders and investors should refer to the actual newspaper publication or the detailed financial results filing for the underlying numbers and performance metrics.
This announcement is a procedural compliance filing and is unlikely to have any direct impact on the stock price. The actual financial performance of the company for FY25 can only be assessed once the detailed audited results are reviewed.